Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Oxford PharmaGenesis welcomes Christopher Rains on board as our first Non-Executive Director

    July 10, 2024 |  

    Oxford PharmaGenesis is proud to announce the appointment of Christopher Rains as our first Non-Executive Director, strengthening the Board with over 30 years of experience in the pharmaceutical industry. A former executive at Takeda, Shire and AstraZeneca, Chris brings unparalleled knowledge and expertise of medical affairs to Oxford PharmaGenesis, with a deep understanding of the challenges in the current pharmaceutical landscape and the strategies required to navigate them.

    - PMLiVE

    Chris’s track record of success in managing global teams and driving growth for large organizations will be invaluable to Oxford PharmaGenesis as we expand our global footprint. His deep insight and understanding of global healthcare and pharma/biotech sectors will enhance our ability to provide innovative solutions to our clients.  

    “I have had the pleasure of working with Oxford PharmaGenesis for many years and am thrilled to join the team as a Non-Executive Director,” says Chris. “This company has a track record of leadership in the medical affairs space, and I look forward to contributing to its continued success.”  

    Oxford PharmaGenesis is a global HealthScience communications consultancy, with a reputation for excellence in the industry. By welcoming Chris Rains to the Board, we are further bolstering our expertise and capabilities, enabling us to serve our clients better and advance our mission to help our clients to accelerate adoption of evidence-based innovations for patients in areas of unmet medical need.  

    For more information about the company, please get in touch.

    This content was provided by Oxford PharmaGenesis

    Company Details

    - PMLiVE

    Oxford PharmaGenesis

    Email
    Website

     Latest Content from  Oxford PharmaGenesis 

    Oxford PharmaGenesis welcomes Christopher Rains on board as our first Non-Executive Director

    Oxford PharmaGenesis is proud to announce the appointment of Christopher Rains as our first Non-Executive Director, strengthening the Board with over 30 years of experience in the pharmaceutical industry. A...

    The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the fourth year running

    For the fourth year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the...

    ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

    Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies.

    HealthScience communications consultancy wins King’s Award

    Oxford PharmaGenesis, the global HealthScience communications consultancy, was honoured on Friday 7 July, by a visit from King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM.

    The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the third year running

    We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.

    Oxford PharmaGenesis wins King’s Award following rapid export growth

    Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country.

    Pharmaceutical companies reduce own greenhouse gas emissions, but action on supply chains needed

    DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public...

    Let’s explore new frontiers

    Ten unbeatable reasons to explore a career with Oxford PharmaGenesis in 2022

    It’s a new year, and a time when many people reflect on whether their role is providing the opportunities, enjoyment and sense of purpose that they deserve. If this sounds...

    Our mission: helping patients in areas of unmet medical need